AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

